Insider Transactions in Q1 2025 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
6,000
-0.72%
|
$300,000
$50.0 P/Share
|
|
Mar 20
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,365
-4.92%
|
$168,250
$50.11 P/Share
|
|
Mar 20
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,186
-5.02%
|
$59,300
$50.11 P/Share
|
|
Mar 20
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
8,534
-13.73%
|
$426,700
$50.11 P/Share
|
|
Mar 20
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,137
-4.41%
|
$106,850
$50.11 P/Share
|
|
Mar 20
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,084
-5.63%
|
$154,200
$50.11 P/Share
|
|
Mar 20
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,435
-2.97%
|
$121,750
$50.11 P/Share
|
|
Mar 19
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,557
-4.94%
|
$167,179
$47.4 P/Share
|
|
Mar 19
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,254
-5.04%
|
$58,938
$47.4 P/Share
|
|
Mar 19
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
8,551
-12.09%
|
$401,897
$47.4 P/Share
|
|
Mar 19
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,259
-4.45%
|
$106,173
$47.4 P/Share
|
|
Mar 19
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,261
-5.62%
|
$153,267
$47.4 P/Share
|
|
Mar 19
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,543
-3.0%
|
$119,521
$47.4 P/Share
|
|
Mar 18
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,643
-4.82%
|
$167,578
$46.29 P/Share
|
|
Mar 18
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,284
-4.91%
|
$59,064
$46.29 P/Share
|
|
Mar 18
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
7,131
-9.16%
|
$328,026
$46.29 P/Share
|
|
Mar 18
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,315
-4.36%
|
$106,490
$46.29 P/Share
|
|
Mar 18
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,341
-5.44%
|
$153,686
$46.29 P/Share
|
|
Mar 18
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,605
-2.99%
|
$119,830
$46.29 P/Share
|
|
Mar 15
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,885
+26.25%
|
-
|
|
Mar 15
2025
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
51,395
+39.77%
|
-
|
|
Mar 15
2025
|
Jeffrey S Farrow Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,019
+23.47%
|
-
|
|
Mar 15
2025
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,957
+21.7%
|
-
|
|
Mar 15
2025
|
Seshadri Neervannan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,264
+19.59%
|
-
|
|
Mar 15
2025
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,213
+23.83%
|
-
|
|
Mar 07
2025
|
Andrew D. Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+34.4%
|
$84,000
$12.89 P/Share
|